Bengt Arne Gustavsson

Bengt Arne Gustavsson is currently the Chairman & Chief Executive Officer at Sangus Jazz AB and also serves as an Independent Director & Medical Director at Nanexa AB.
Previously, he held positions such as Director-Nordic Clinical Research at Sanofi Aventis AB from 2005 to 2007, Director-Nordic Medical at Novartis Oncology Switzerland from 2002 to 2005 and from 2007 to 2011, Director at Wntresearch AB, Global Head-Medical Affairs at Oncopeptides AB, and Head-Nordic Medical at Celgene AB from 2012 to 2017.
Dr. Gustavsson obtained a doctorate degree from the University of Uppsala in 1994, an undergraduate degree from the University of Uppsala in 1987, and another undergraduate degree from the University of Basel in 1999.